Home / Knowledge Centre /

World CB & CDx- An interview with Dr Jude O’Donnell

Ahead of the digital 11th World Clinical Biomarkers & CDx Summit (Sept29– 30), Dr Jude O’Donnell spoke to World CB & CDx on her experience of planning ahead when it comes to clinical trial assay and CDx development and tying this to Dx performance, regulatory compliance and downstream success of a drug development program.

Read the full article below- total read time 10 minutes.

You can also register for World CB & CDx here.


View Resource
Almac Logo

Diagnostic Services

Your global partner for biomarker discovery, development & commercialisation.

Genomic Services

We offer a range of genomics platform and chemistry options, alongside expert data sciences support and a full sample management service.

Clinical Trial Assays

Comprehensive development, validation & delivery service for research and clinical use assays from our global clinical laboratories in USA, Europe and APAC.

Companion Diagnostics

A collaborative Companion Diagnostic partnership approach with a deep understanding of client needs. We offer CDx development, manufacture & commercialisation services.

Learn More

Please complete this form to view the Article

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies